Pasithea Therapeutics (KTTA) Q4 2024 Annual Earnings

KTTA·Reported March 24, 2025·Before market open

Diluted EPS came in at $-2.41.

Diluted EPS

$-2.41

SEC Filings

Earnings release8-K not filed yet

Annual report10-K · 0001013762-25-001646

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Q4 2024 Earnings FAQ

Common questions about Pasithea Therapeutics's Q4 2024 earnings report.

Pasithea Therapeutics (KTTA) reported Q4 2024 earnings on March 24, 2025 before market open.

Pasithea Therapeutics reported diluted EPS of $-2.41 for Q4 2024.

You can read the 10-K periodic report (0001013762-25-001646) directly on SEC EDGAR. The filing index links above go to sec.gov.